PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma

被引：0
|
作者：
Verena Sailer
Emily Eva Holmes
Heidrun Gevensleben
Diane Goltz
Freya Dröge
Alina Franzen
Jörn Dietrich
Glen Kristiansen
Friedrich Bootz
Andreas Schröck
Dimo Dietrich
机构：
[1] Weill Cornell Medicine,Department of Pathology and Laboratory Medicine
[2] Weill Cornell Medicine,Caryl and Israel Englander Institute for Precision Medicine
[3] University Hospital Bonn,Institute of Pathology
[4] University Hospital Cologne,Institute of Pathology
[5] University Hospital Essen,Department of Otorhinolaryngology
[6] University of Duisburg-Essen,Department of Otolaryngology, Head and Neck Surgery
[7] University Hospital Bonn,undefined
来源：
Clinical Epigenetics | 2017年 / 9卷
关键词：
Biomarker; Head and neck squamous cell carcinoma; HNSCC; DNA methylation; HPV; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PITX3 DNA methylation is an independent predictor of overall survival in patients with head and neck squamous cell carcinoma
    Sailer, Verena
    Holmes, Emily Eva
    Gevensleben, Heidrun
    Goltz, Diane
    Droege, Freya
    Franzen, Alina
    Dietrich, Joern
    Kristiansen, Glen
    Bootz, Friedrich
    Schroeck, Andreas
    Dietrich, Dimo
    CLINICAL EPIGENETICS, 2017, 9
  • [2] PITX2 and PANCR DNA methylation predicts overall survival in patients with head and neck squamous cell carcinoma
    Sailer, Verena
    Holmes, Emily Eva
    Gevensleben, Heidrun
    Goltz, Diane
    Droege, Freya
    de Vos, Luka
    Franzen, Alina
    Schroeck, Friederike
    Bootz, Friedrich
    Kristiansen, Glen
    Schroeck, Andreas
    Dietrich, Dimo
    ONCOTARGET, 2016, 7 (46) : 75827 - 75838
  • [3] Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
    Xu, Yuanyuan
    Hong, Min
    Kong, Deyu
    Deng, Jun
    Zhong, Zhaoming
    Liang, Jin
    BMC GENOMICS, 2022, 23 (01)
  • [4] Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma
    Yuanyuan Xu
    Min Hong
    Deyu Kong
    Jun Deng
    Zhaoming Zhong
    Jin Liang
    BMC Genomics, 23
  • [5] Sixteen Cellular Senescence-associated DNA Methylation Signature Predicts Overall Survival in Patients with Head and Neck Squamous Cell Carcinoma
    Ye, Ming Han
    Huang, Xin Yi
    Li, Chun Jie
    Wu, Qian Ju
    Liu, Fei
    CHINESE JOURNAL OF DENTAL RESEARCH, 2023, 26 (04): : 235 - 248
  • [6] Clinical performance validation of PITX2 DNA methylation as prognostic biomarker in patients with head and neck squamous cell carcinoma
    Sailer, Verena
    Gevensleben, Heidrun
    Dietrich, Joern
    Goltz, Diane
    Kristiansen, Glen
    Bootz, Friedrich
    Dietrich, Dimo
    PLOS ONE, 2017, 12 (06):
  • [7] The expression and methylation of PITX genes is associated with the prognosis of head and neck squamous cell carcinoma
    Zhao, Yaqiong
    Zhao, Jie
    Zhong, Mengmei
    Zhang, Qian
    Yan, Fei
    Feng, Yunzhi
    Guo, Yue
    FRONTIERS IN GENETICS, 2022, 13
  • [8] Detection of aberrant DNA methylation in saliva samples as a predictor of recurrence in head and neck squamous cell carcinoma patients
    de Carvalho, Ana Carolina
    Rettori, Marianna M.
    Maia, Danielle C. C.
    Carvalho, Andre L.
    Kowalski, Luiz P.
    Vettore, Andre L.
    CANCER RESEARCH, 2011, 71
  • [9] DNA methylation biomarkers for head and neck squamous cell carcinoma
    Zhou, Chongchang
    Ye, Meng
    Ni, Shumin
    Li, Qun
    Ye, Dong
    Li, Jinyun
    Shen, Zhisen
    Deng, Hongxia
    EPIGENETICS, 2018, 13 (04) : 398 - 409
  • [10] MicroRNA-137 Promoter Methylation Is Associated With Poorer Overall Survival in Patients With Squamous Cell Carcinoma of the Head And Neck
    Langevin, Scott M.
    Stone, Roslyn A.
    Bunker, Clareann H.
    Lyons-Weiler, Maureen A.
    LaFramboise, William A.
    Kelly, Lori
    Seethala, Raja R.
    Grandis, Jennifer R.
    Sobol, Robert W.
    Taioli, Emanuela
    CANCER, 2011, 117 (07) : 1454 - 1462
12345